Nexalin Technology (NXL) Gross Profit Growth (3y) (2024 - 2026)
Nexalin Technology (NXL) Gross Profit Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 9.77% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 12.24% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 14.82% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 9.36% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 14.95% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 3.96% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 3.99% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 8.95% |
| 10 | Nexalin Technology | 6.98 Mn | 5.97 Mn | 8,897.00 | -30.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -30.20% |
| Mar 31, 2026 | -17.57% |
| Dec 31, 2025 | 68.46% |
| Sep 30, 2025 | -65.90% |
| Jun 30, 2025 | -45.27% |
| Mar 31, 2025 | -53.74% |
| Dec 31, 2024 | -7.67% |
| Sep 30, 2024 | -20.62% |